Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 35, Issue 2, Pages 452-460
Publisher
Oxford University Press (OUP)
Online
2013-09-26
DOI
10.1093/carcin/bgt316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies
- (2013) Chang Hui et al. PLoS One
- Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice
- (2013) Sanjeev Shukla et al. PROSTATE
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer genetics and genomics of human FOX family genes
- (2012) Masuko Katoh et al. CANCER LETTERS
- Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma
- (2012) H. Wang et al. CLINICAL CANCER RESEARCH
- Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells
- (2012) Shingo Kagawa et al. JOURNAL OF SURGICAL RESEARCH
- FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- FoxO family members in cancer
- (2011) Yuqing Zhang et al. CANCER BIOLOGY & THERAPY
- Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model
- (2011) Sanjeev Shukla et al. PHARMACEUTICAL RESEARCH
- Applications of post-translational modifications of FoxO family proteins in biological functions
- (2011) Ying Zhao et al. Journal of Molecular Cell Biology
- Induction of Clusterin by AKT--Role in Cytoprotection against Docetaxel in Prostate Tumor Cells
- (2010) B. Zhong et al. MOLECULAR CANCER THERAPEUTICS
- Apigenin: A Promising Molecule for Cancer Prevention
- (2010) Sanjeev Shukla et al. PHARMACEUTICAL RESEARCH
- Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells
- (2010) Qinghe Chen et al. PLoS One
- PTEN Deficiency Is Fully Penetrant for Prostate Adenocarcinoma in C57BL/6 Mice via mTOR-Dependent Growth
- (2009) Jorge Blando et al. AMERICAN JOURNAL OF PATHOLOGY
- Dietary flavonoid intake and colorectal cancer: a case–control study
- (2009) Janet A. M. Kyle et al. BRITISH JOURNAL OF NUTRITION
- The Chemopreventive Bioflavonoid Apigenin Inhibits Prostate Cancer Cell Motility through the Focal Adhesion Kinase/Src Signaling Mechanism
- (2009) C. A. Franzen et al. Cancer Prevention Research
- The PKB/AKT Pathway in Cancer
- (2009) Amancio Carnero CURRENT PHARMACEUTICAL DESIGN
- PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
- (2009) Kanishka Sircar et al. JOURNAL OF PATHOLOGY
- Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis
- (2008) S. Shankar et al. CLINICAL CANCER RESEARCH
- Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation
- (2008) Sanjeev Shukla et al. FREE RADICAL BIOLOGY AND MEDICINE
- Flavonoid intake and ovarian cancer risk in a population-based case-control study
- (2008) Margaret A. Gates et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells
- (2008) Guixia Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now